Gene: LMCD1
Official Full Name: LIM and cysteine rich domains 1provided by HGNC
Gene Summary: This gene encodes a member of the LIM-domain family of zinc finger proteins. The encoded protein contains an N-terminal cysteine-rich domain and two C-terminal LIM domains. The presence of LIM domains suggests involvement in protein-protein interactions. The protein may act as a co-regulator of transcription along with other transcription factors. Alternate splicing results in multiple transcript variants of this gene. [provided by RefSeq, May 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26844 | LMCD1 Knockout cell line (HeLa) | Human | LMCD1 | 1:3~1:6 | Negative | Online Inquiry |
KO26845 | LMCD1 Knockout cell line (HCT 116) | Human | LMCD1 | 1:2~1:4 | Negative | Online Inquiry |
KO26846 | LMCD1 Knockout cell line (HEK293) | Human | LMCD1 | 1:3~1:6 | Negative | Online Inquiry |
KO26847 | LMCD1 Knockout cell line (A549) | Human | LMCD1 | 1:3~1:4 | Negative | Online Inquiry |
LMCD1 Gene Knockout Cell Lines represent a cutting-edge biological tool designed to facilitate the functional analysis of the LMCD1 gene. These genetically modified cell lines are created using advanced CRISPR-Cas9 technology to disrupt the expression of the LMCD1 gene, enabling researchers to investigate its role in cellular processes. By eliminating the LMCD1 gene, these knockout cell lines provide a unique platform for studying gene function, signaling pathways, and gene-environment interactions.
The primary mechanism of action involves precise alterations to the genomic DNA, resulting in a complete loss of LMCD1 protein production. This permits in-depth studies on the gene's involvement in various physiological and pathological processes, including cell proliferation, differentiation, and apoptosis. Additionally, LMCD1 knockout cells can be beneficial in identifying novel drug targets and elucidating mechanisms underlying disease states, such as cancer or metabolic disorders.
The scientific importance of LMCD1 Gene Knockout Cell Lines extends to both basic and applied research. In a clinical context, these cell lines hold potential for the development of targeted therapies and personalized medicine approaches, as they enable the dissection of cellular responses that are crucial for understanding patient-specific diseases.
Compared to alternative gene-editing tools, LMCD1 Gene Knockout Cell Lines offer several advantages including higher efficiency, specificity, and a reduced risk of off-target effects inherent in other methods. Their ready-to-use format accelerates experimental timelines, allowing researchers to focus on obtaining meaningful results rather than troubleshooting cell line development.
For researchers, clinicians, and biotech companies, the ability to directly manipulate genes is invaluable in advancing our understanding of complex biological systems. This product empowers scientific discovery and facilitates breakthroughs in therapeutic development. Our company specializes in the creation of advanced genetic tools and robust cell models, ensuring our products meet the highest standards of quality and efficacy for the demanding needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.